Emerging Targeted Therapy for Bladder Cancer

Constance Thibault; Yohann Loriot

doi:10.1016/j.hoc.2021.02.011

Emerging Targeted Therapy for Bladder Cancer

Constance Thibault, Yohann Loriot

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

4 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	585-596
Nombre de pages	12
journal	Hematology/Oncology Clinics of North America
Volume	35
Numéro de publication	3
Les DOIs	https://doi.org/10.1016/j.hoc.2021.02.011
état	Publié - 1 juin 2021

Accès au document

10.1016/j.hoc.2021.02.011

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{1db5f0db86424cb194b863774f7732b8,

title = "Emerging Targeted Therapy for Bladder Cancer",

keywords = "Antiangiogenic, Conjugated antibodies, FGFR inhibitors, PARP inhibitors, Targeted therapies, Urothelial carcinoma",

author = "Constance Thibault and Yohann Loriot",

year = "2021",

month = jun,

day = "1",

doi = "10.1016/j.hoc.2021.02.011",

language = "English",

volume = "35",

pages = "585--596",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

number = "3",

}

TY - JOUR

T1 - Emerging Targeted Therapy for Bladder Cancer

AU - Thibault, Constance

AU - Loriot, Yohann

PY - 2021/6/1

Y1 - 2021/6/1

KW - Antiangiogenic

KW - Conjugated antibodies

KW - FGFR inhibitors

KW - PARP inhibitors

KW - Targeted therapies

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85104333119&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2021.02.011

DO - 10.1016/j.hoc.2021.02.011

M3 - Review article

C2 - 33958152

AN - SCOPUS:85104333119

SN - 0889-8588

VL - 35

SP - 585

EP - 596

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 3

ER -